Beyondspring (BYSI) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BeyondSpring Inc., a biopharmaceutical company, has successfully filed a registration statement with the SEC for the issuance of over 1.2 million ordinary shares, as detailed in a prospectus supplement dated June 12, 2024. This move, executed in accordance with a Securities Purchase Agreement, aims to strengthen the company’s financial position. Legal opinions confirm that the shares, once issued and paid for, will be fully legitimate and non-assessable under Cayman Islands law.
For further insights into BYSI stock, check out TipRanks’ Stock Analysis page.
